2
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T68937 |
Carbidopa hydrochloride
|
||
Carbidopa hydrochloride is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa. This property is significant in that it allows a greater proportion of peripheral levodopa to cross the blood–brain barrier for central nervous system effect. | |||
T2148 |
Carbidopa monohydrate
Carbidopa Hydrate,S(-)-Carbidopa,卡比多巴水合物 |
Decarboxylase; Aryl Hydrocarbon Receptor | Immunology/Inflammation; Metabolism; Others |
Carbidopa monohydrate (S(-)-Carbidopa) 是一种外周型脱羧酶抑制剂,可用于帕金森病的研究。它是一种选择性芳香烃受体 (AhR) 调节剂。它抑制胰腺癌细胞和肿瘤生长。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6795 |
Carbidopa
卡比多巴,(S)-(-)-Carbidopa,Lodosyn |
Decarboxylase; Aryl Hydrocarbon Receptor | Immunology/Inflammation; Metabolism; Others |
Carbidopa (Lodosyn) 是一种选择性芳香烃受体(AhR)调节剂,是外周型脱羧酶抑制剂,抑制胰腺癌细胞和肿瘤生长,可用于帕金森病的研究。 |